Related Experiment Video
Updated: Dec 23, 2025

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
The DNMT1/miR-34a/FOXM1 Axis Contributes to Stemness of Liver Cancer Cells
Xiaocheng Cao1,2,3, Lihua Liu4,5, Xiaozheng Cao4,5
1Key Laboratory of Study and Discover of Small Targeted Molecules of Hunan Province, Medical College, Hunan Normal University, Changsha, Hunan 410013, China.
Background:
Whether DNA methyltransferase 1 (DNMT1)/miR-34a/FoxM1 signaling promotes the stemness of liver cancer stem cells (LCSCs) remains unclear. This study aimed to assess whether methylation-based silencing of miR-34a by DNMT1 contributes to stemness features via FoxM1 upregulation in LCSCs.
Methods:
The CD133+ subgroup of MHCC97H cells sorted by MACS was used as LCSCs. DNMT1, BMI1, SOX2, and OCT4 mRNA levels, and miR-34a amounts were determined by qRT-PCR. DNMT1, CD44, and FoxM1 proteins were analyzed by immunoblot. Sphere and colony formation abilities were detected by respective assays. CD133+ cell percentages were assessed by flow cytometry. In vivo oncogenicity was evaluated using a tumor xenograft model in mice. The effects of DNMT1/miR-34a signaling on the stemness of LCSCs were examined by knockdown or overexpression of DNMT1 and/or transfection of miR-34a mimic or inhibitor using lentivirus-delivery systems. FoxM1 association with miR-34a was detected by a reporter assay.
Results:
We here showed that LCSCs exhibited elevated DNMT1 activity and expression, lower miR-34a expression with higher promoter methylation, and stronger stemness, compared with the parental liver cancer cells. DNMT1 knockdown repressed DNMT1, increased miR-34a amounts by promoter demethylation, and reduced stemness in LCSCs, whereas DNMT1 overexpression had the opposite effects in liver cancer cells. Transfection with miR-34a mimic repressed the stemness of LCSCs, while miR-34a inhibitor significantly downregulated miR-34a and enhanced stemness, without affecting DNMT1 in liver cancer cells. MiR-34a mimic rescued the effects of DNMT1 overexpression on the stemness of LCSCs, without affecting DNMT1 expression. Finally, FOXM1 was identified as a direct target by miR-34a in LCSCs.
Conclusions:
We revealed that aberrant activation of DNMT1 causes miR-34a promoter methylation and suppression, leading to FoxM1 upregulation by disinhibition and promotion of LCSC stemness. These findings suggest that blockage of DNMT1/miR-34a-mediated FOXM1 upregulation might suppress liver cancer by targeting LCSCs.
Insights
Aberrant DNA methyltransferase 1 (DNMT1) activates liver cancer stem cells (LCSCs) by silencing miR-34a, leading to FoxM1 upregulation and promoting stemness. Targeting this DNMT1/miR-34a pathway may suppress liver cancer.
Area of Science:
- Molecular Biology
- Cancer Stem Cell Biology
- Epigenetics
Background:
- Liver cancer stem cells (LCSCs) possess self-renewal and differentiation capabilities, driving tumor initiation and recurrence.
- The role of DNA methyltransferase 1 (DNMT1)/miR-34a/FoxM1 signaling in LCSC stemness remains incompletely understood.
Purpose of the Study:
- To investigate whether DNMT1-mediated methylation of miR-34a contributes to LCSC stemness through FoxM1 upregulation.
Main Methods:
- Utilized CD133+ MHCC97H cells as LCSCs.
- Quantified gene and microRNA expression via qRT-PCR.
- Assessed protein levels using immunoblotting.
- Evaluated stemness properties through sphere and colony formation assays, and flow cytometry.
- Investigated in vivo oncogenicity in a mouse xenograft model.
- Manipulated DNMT1 and miR-34a levels using lentiviral systems.
- Confirmed FoxM1 as a miR-34a target using a reporter assay.
Main Results:
- LCSCs showed higher DNMT1, lower miR-34a, and increased stemness compared to parental cells.
- DNMT1 knockdown reduced DNMT1, increased miR-34a, and decreased stemness.
- miR-34a mimic transfection suppressed LCSC stemness, while miR-34a inhibitor enhanced it.
- FoxM1 was identified as a direct target of miR-34a in LCSCs.
Conclusions:
- Aberrant DNMT1 activation leads to miR-34a promoter methylation, suppressing miR-34a and upregulating FoxM1, thereby promoting LCSC stemness.
- Inhibition of the DNMT1/miR-34a-FoxM1 axis presents a potential therapeutic strategy for liver cancer targeting LCSCs.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cell Specific Gene Expression
Inheritance of Chromatin Structures